Tag: Diabetes: Type II
Gender, Race Affects Access to SGLT2-Inhibitor Therapy for T2DM
Women, Black or Asian patients less likely to receive sodium-glucose cotransporter 2 inhibitor treatment for type 2 diabetes
USPSTF Urges Prediabetes, T2DM Screen for Overweight Adults
Physicians should screen overweight, obese adults aged 35 to 70 years and refer those with prediabetes to preventive interventions
Timing of Exercise May Be Linked to Cardiovascular Fitness
Associations significant for men with type 2 diabetes, but less so for women
Semaglutide May Aid Weight Loss in Obese Patients With T2DM
Estimated change in mean body weight to week 68 was −9.6 percent with semaglutide 2.4 mg versus −3.4 percent with placebo
CVD Risk Factors Tied to Cognitive Impairment in Schizophrenia
Significantly greater global cognitive deficits seen in those with schizophrenia who had metabolic syndrome, diabetes, hypertension
Provider Teams Outperform Solo Care for New-Onset Chronic Disease
Among solo providers, there was little difference in care management and outcomes between physicians, nonphysicians
Birth Weight Modifies Link Between Adult IGF-1 Levels, T2DM
IGF-1 levels inversely associated with T2DM risk in dose-dependent manner, but only among those with birth weight ≥2.5 kg
Prediabetes, Type 2 Diabetes Tied to Poorer Brain Health
Higher risk for cognitive decline, vascular dementia, Alzheimer disease seen with high blood glucose
Polynesian Ancestry May Increase Cardiometabolic Risk
Genetic study reveals link between Polynesian ancestry and higher risk for obesity, T2DM, heart failure in Native Hawaiians
Risk for Rheumatoid Arthritis Reduced for Patients With T2DM
Reduced risk may be attributable to statin use; no significant association seen for glycemic control, metformin use on RA risk
